The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis

The impact of oxidative stress in human cancer has been extensively studied. It is accepted that elevated reactive oxygen species (ROS) promote mutagenic DNA damage. Even with an extensive armament of cellular antioxidants and detoxification enzymes, alterations to DNA occur that initiate cellular t...

Full description

Saved in:
Bibliographic Details
Published in:Oncogene Vol. 27; no. 31; pp. 4353 - 4362
Main Authors: Frohlich, D A, McCabe, M T, Arnold, R S, Day, M L
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 17-07-2008
Nature Publishing
Nature Publishing Group
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The impact of oxidative stress in human cancer has been extensively studied. It is accepted that elevated reactive oxygen species (ROS) promote mutagenic DNA damage. Even with an extensive armament of cellular antioxidants and detoxification enzymes, alterations to DNA occur that initiate cellular transformation. Erythroid 2p45 (NF-E2)-related factor 2 (Nrf2) is a basic-region leucine zipper transcription factor that mediates the expression of key protective enzymes through the antioxidant-response element (ARE). By analysing 10 human prostate cancer microarray data sets, we have determined that Nrf2 and members of the glutathione- S -transferase (GST) mu family are extensively decreased in human prostate cancer. Using the TRAMP transgene and Rb and Nrf2 knockout murine models, we demonstrated that the loss of Nrf2 initiates a detrimental cascade of reduced GST expression, elevated ROS levels and ultimately DNA damage associated with tumorigenesis. Based on overwhelming data from clinical samples and the current functional analysis, we propose that the disruption of the Nrf2-antioxidant axis leads to increased oxidative stress and DNA damage in the initiation of cellular transformation in the prostate gland.
AbstractList The impact of oxidative stress in human cancer has been extensively studied. It is accepted that elevated reactive oxygen species (ROS) promote mutagenic DNA damage. Even with an extensive armament of cellular antioxidants and detoxification enzymes, alterations to DNA occur that initiate cellular transformation. Erythroid 2p45 (NF-E2)-related factor 2 (Nrf2) is a basic-region leucine zipper transcription factor that mediates the expression of key protective enzymes through the antioxidant-response element (ARE). By analysing 10 human prostate cancer microarray data sets, we have determined that Nrf2 and members of the glutathione-S-transferase (GST) mu family are extensively decreased in human prostate cancer. Using the TRAMP transgene and Rb and Nrf2 knockout murine models, we demonstrated that the loss of Nrf2 initiates a detrimental cascade of reduced GST expression, elevated ROS levels and ultimately DNA damage associated with tumorigenesis. Based on overwhelming data from clinical samples and the current functional analysis, we propose that the disruption of the Nrf2-antioxidant axis leads to increased oxidative stress and DNA damage in the initiation of cellular transformation in the prostate gland. [PUBLICATION ABSTRACT]
The impact of oxidative stress in human cancer has been extensively studied. It is accepted that elevated reactive oxygen species (ROS) promote mutagenic DNA damage. Even with an extensive armament of cellular antioxidants and detoxification enzymes, alterations to DNA occur that initiate cellular transformation. Erythroid 2p45 (NF-E2)-related factor 2 (Nrf2) is a basic-region leucine zipper transcription factor that mediates the expression of key protective enzymes through the antioxidant-response element (ARE). By analysing 10 human prostate cancer microarray data sets, we have determined that Nrf2 and members of the glutathione-S-transferase (GST) mu family are extensively decreased in human prostate cancer. Using the TRAMP transgene and Rb and Nrf2 knockout murine models, we demonstrated that the loss of Nrf2 initiates a detrimental cascade of reduced GST expression, elevated ROS levels and ultimately DNA damage associated with tumorigenesis. Based on overwhelming data from clinical samples and the current functional analysis, we propose that the disruption of the Nrf2-antioxidant axis leads to increased oxidative stress and DNA damage in the initiation of cellular transformation in the prostate gland.
The impact of oxidative stress in human cancer has been extensively studied. It is accepted that elevated reactive oxygen species (ROS) promote mutagenic DNA damage. Even with an extensive armament of cellular antioxidants and detoxification enzymes, alterations to DNA occur that initiate cellular transformation. Erythroid 2p45 (NF-E2)-related factor 2 (Nrf2) is a basic-region leucine zipper transcription factor that mediates the expression of key protective enzymes through the antioxidant-response element (ARE). By analysing 10 human prostate cancer microarray data sets, we have determined that Nrf2 and members of the glutathione-S-transferase (GST) mu family are extensively decreased in human prostate cancer. Using the TRAMP transgene and Rb and Nrf2 knockout murine models, we demonstrated that the loss of Nrf2 initiates a detrimental cascade of reduced GST expression, elevated ROS levels and ultimately DNA damage associated with tumorigenesis. Based on overwhelming data from clinical samples and the current functional analysis, we propose that the disruption of the Nrf2-antioxidant axis leads to increased oxidative stress and DNA damage in the initiation of cellular transformation in the prostate gland.Oncogene (2008) 27, 4353-4362; doi:10.1038/onc.2008.79; published online 31 March 2008
The impact of oxidative stress in human cancer has been extensively studied. It is accepted that elevated reactive oxygen species (ROS) promote mutagenic DNA damage. Even with an extensive armament of cellular antioxidants and detoxification enzymes, alterations to DNA occur that initiate cellular transformation. Erythroid 2p45 (NF-E2)-related factor 2 (Nrf2) is a basic-region leucine zipper transcription factor that mediates the expression of key protective enzymes through the antioxidant-response element (ARE). By analysing 10 human prostate cancer microarray data sets, we have determined that Nrf2 and members of the glutathione- S -transferase (GST) mu family are extensively decreased in human prostate cancer. Using the TRAMP transgene and Rb and Nrf2 knockout murine models, we demonstrated that the loss of Nrf2 initiates a detrimental cascade of reduced GST expression, elevated ROS levels and ultimately DNA damage associated with tumorigenesis. Based on overwhelming data from clinical samples and the current functional analysis, we propose that the disruption of the Nrf2-antioxidant axis leads to increased oxidative stress and DNA damage in the initiation of cellular transformation in the prostate gland.
Audience Academic
Author Day, M L
McCabe, M T
Arnold, R S
Frohlich, D A
Author_xml – sequence: 1
  givenname: D A
  surname: Frohlich
  fullname: Frohlich, D A
  organization: Department of Urology, UMCC, University of Michigan
– sequence: 2
  givenname: M T
  surname: McCabe
  fullname: McCabe, M T
  organization: Department of Radiation Oncology, Emory University School of Medicine
– sequence: 3
  givenname: R S
  surname: Arnold
  fullname: Arnold, R S
  organization: Department of Pathology and Laboratory Medicine, Emory University School of Medicine
– sequence: 4
  givenname: M L
  surname: Day
  fullname: Day, M L
  email: mday@umich.edu
  organization: Department of Urology, UMCC, University of Michigan
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20593586$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18372916$$D View this record in MEDLINE/PubMed
BookMark eNqF0s1rFDEUAPAgFfuhJ-86KHrRXfM9yXGpn1DqpV4N2eRlTZnJbJMZsf-9GXbpolQkA4HJ7728JO8UHaUhAUJPCV4SzNS7IbklxVgtW_0AnRDeyoUQmh-hE6wFXmjK6DE6LeUaY9xqTB-hY6JYSzWRJ-j71Q9o8tBBM4TmMgfaxFQ_l8EW8E2d3Bh_1tVftxtITdmCi1Aam3zz_nLVeNvbDcwx2zyU0Y7QjFM_5FgxlFgeo4fBdgWe7Ocz9O3jh6vzz4uLr5--nK8uFk5KMS4kA9J6wW1QWAW1tnjNpQYiLHhl10pJhbnyFqQE79aShMBF4D5ghgn2lJ2h17u8tYybCcpo-lgcdJ1NMEzFUMKwlKz9LyS65UozVuHLv-D1MOVUD2Go5IQpoaiq6sU_FW2ZaBXWh1Qb24GJKQxjtm7e16yIrm_CJZ9TLe9RdXjoo6tPHmL9_0fAm12Aq1dfMgSzzbG3-dYQbObOMLUzzNwZpp2LeLavdFr34A923woVvNoDW5ztQrbJxXLnKBaaCTW7tztX6lLaQD4c-f59n-94suOU4S5fNTOp4je7GNjv
CODEN ONCNES
CitedBy_id crossref_primary_10_1016_j_freeradbiomed_2013_02_009
crossref_primary_10_1371_journal_pone_0008579
crossref_primary_10_18632_oncotarget_9245
crossref_primary_10_1158_0008_5472_CAN_08_2492
crossref_primary_10_1631_jzus_B1500296
crossref_primary_10_1021_acs_chemrestox_6b00016
crossref_primary_10_1101_gad_1965810
crossref_primary_10_1016_j_bcp_2011_12_027
crossref_primary_10_1016_j_ejcb_2021_151181
crossref_primary_10_1007_s00411_009_0244_x
crossref_primary_10_3390_biomedicines8050122
crossref_primary_10_1155_2016_5845061
crossref_primary_10_1208_s12248_013_9493_3
crossref_primary_10_1007_s10565_013_9242_5
crossref_primary_10_1002_mc_21950
crossref_primary_10_1002_mnfr_201500847
crossref_primary_10_1016_j_bcp_2013_02_010
crossref_primary_10_1016_j_semcancer_2023_03_002
crossref_primary_10_1016_j_jcmgh_2021_02_004
crossref_primary_10_1158_1940_6207_CAPR_14_0127
crossref_primary_10_1016_j_lfs_2018_07_008
crossref_primary_10_1186_1471_2164_11_26
crossref_primary_10_3390_cancers2020483
crossref_primary_10_1016_j_bbagen_2016_06_022
crossref_primary_10_1007_s11356_020_08412_0
crossref_primary_10_1093_carcin_bgaa039
crossref_primary_10_1007_s00204_011_0674_5
crossref_primary_10_1002_mc_22776
crossref_primary_10_3390_insects11040221
crossref_primary_10_15252_emmm_201404181
crossref_primary_10_3389_fphys_2022_989793
crossref_primary_10_1016_j_bcp_2011_07_065
crossref_primary_10_1016_j_foodchem_2012_03_108
crossref_primary_10_1089_ars_2017_7485
crossref_primary_10_1186_s40798_020_0242_8
crossref_primary_10_18632_oncotarget_2230
crossref_primary_10_1186_1471_2156_14_23
crossref_primary_10_1371_journal_pone_0024004
crossref_primary_10_1021_acs_chemrestox_7b00248
crossref_primary_10_1021_tx1004369
crossref_primary_10_3390_antiox10081209
crossref_primary_10_3389_fcell_2017_00065
crossref_primary_10_1038_pcan_2013_13
crossref_primary_10_1038_nrgastro_2012_114
crossref_primary_10_1080_00498250802549808
crossref_primary_10_1039_C8FO00018B
crossref_primary_10_1007_s11033_022_08052_2
crossref_primary_10_1002_mnfr_201000648
crossref_primary_10_3390_ijms24054482
crossref_primary_10_1016_j_critrevonc_2020_102885
crossref_primary_10_1038_onc_2010_118
crossref_primary_10_1016_j_freeradbiomed_2015_06_013
crossref_primary_10_1038_onc_2012_623
crossref_primary_10_1042_BJ20110744
crossref_primary_10_1016_j_biopha_2018_07_022
crossref_primary_10_1155_2014_313015
crossref_primary_10_3390_nu3110962
crossref_primary_10_3892_etm_2018_6208
crossref_primary_10_1080_01635581_2017_1248296
crossref_primary_10_3390_biom13020353
crossref_primary_10_1177_0748233712466132
crossref_primary_10_1038_s41388_021_01993_1
crossref_primary_10_1111_jpi_12142
crossref_primary_10_1007_s00204_011_0675_4
crossref_primary_10_1016_j_bbcan_2014_09_004
crossref_primary_10_18632_oncotarget_16622
crossref_primary_10_1016_j_drup_2022_100865
crossref_primary_10_3390_cancers12051178
crossref_primary_10_1002_mc_22164
crossref_primary_10_1038_s41419_017_0250_x
crossref_primary_10_1371_journal_pone_0026884
crossref_primary_10_1002_biof_1200
crossref_primary_10_3389_fimmu_2016_00278
crossref_primary_10_1016_j_ebiom_2019_06_022
crossref_primary_10_3389_fgene_2020_00818
crossref_primary_10_1016_j_freeradbiomed_2016_03_015
crossref_primary_10_1111_imb_12230
crossref_primary_10_1002_cam4_2101
crossref_primary_10_1007_s12272_021_01316_8
crossref_primary_10_3390_biomedicines11061628
crossref_primary_10_46373_hafebid_1442953
crossref_primary_10_1124_jpet_116_238048
crossref_primary_10_12677_ACM_2023_13102289
crossref_primary_10_1002_pros_20976
crossref_primary_10_1016_j_taap_2016_01_023
crossref_primary_10_3390_ijms20123046
crossref_primary_10_1089_ars_2009_2541
crossref_primary_10_1016_j_canlet_2019_03_020
crossref_primary_10_3945_jn_111_153114
crossref_primary_10_1007_s11805_011_0563_y
crossref_primary_10_3390_antiox9030193
crossref_primary_10_1016_j_urolonc_2024_01_007
crossref_primary_10_1016_j_redox_2015_06_014
crossref_primary_10_1016_j_taap_2017_06_005
crossref_primary_10_1016_j_bbrc_2012_10_010
crossref_primary_10_1016_j_taap_2009_11_028
crossref_primary_10_3390_biom12060766
crossref_primary_10_1002_mc_21886
crossref_primary_10_1093_gerona_glq181
crossref_primary_10_3390_ijms23105397
crossref_primary_10_1016_j_wneu_2011_09_055
crossref_primary_10_1016_j_biocel_2019_105667
crossref_primary_10_1208_s12248_016_0016_x
crossref_primary_10_1158_0008_5472_CAN_12_4400
crossref_primary_10_1016_j_canlet_2008_12_011
crossref_primary_10_1097_JTO_0000000000000219
crossref_primary_10_1089_ars_2010_3276
crossref_primary_10_1111_jfbc_12168
crossref_primary_10_1242_dev_178335
crossref_primary_10_37212_jcnos_334360
crossref_primary_10_1002_advs_202205302
crossref_primary_10_1016_j_wneu_2011_06_063
crossref_primary_10_1210_endocr_bqac191
crossref_primary_10_1134_S0006297922050030
crossref_primary_10_1016_j_tibs_2008_12_008
crossref_primary_10_1007_s42764_020_00010_1
crossref_primary_10_1016_j_molcel_2010_10_004
crossref_primary_10_1016_j_bbcan_2008_11_001
crossref_primary_10_3390_cancers13236062
crossref_primary_10_1002_mc_20841
crossref_primary_10_1158_1541_7786_MCR_11_0033
crossref_primary_10_3390_ijerph17041441
crossref_primary_10_1038_s41598_019_51954_8
crossref_primary_10_1093_nar_gkp865
crossref_primary_10_3390_ijms221910537
crossref_primary_10_1016_j_abb_2020_108326
crossref_primary_10_3389_fncel_2019_00325
crossref_primary_10_1016_j_ccell_2018_03_022
crossref_primary_10_1038_onc_2015_178
crossref_primary_10_1371_journal_pone_0005492
crossref_primary_10_1038_s41467_023_36124_9
crossref_primary_10_1016_j_bbalip_2013_09_004
crossref_primary_10_1091_mbc_e13_11_0692
crossref_primary_10_3390_cancers2021354
crossref_primary_10_1002_tox_22707
crossref_primary_10_1038_onc_2010_153
crossref_primary_10_18632_oncotarget_12860
crossref_primary_10_3390_biomedicines10102668
Cites_doi 10.3109/10409239509083491
10.2353/ajpath.2006.051113
10.1002/pros.20313
10.1172/JCI20032
10.1196/annals.1386.005
10.1006/bbrc.2001.5944
10.1158/0008-5472.CAN-05-1948
10.1074/jbc.M205361200
10.1073/pnas.92.8.3439
10.1146/annurev.pharmtox.45.120403.095857
10.1073/pnas.101505898
10.1002/(SICI)1097-0045(19970901)32:4<229::AID-PROS1>3.0.CO;2-E
10.1093/oxfordjournals.bmb.a072628
10.1038/nrc2090
10.1038/35090585
10.1158/0008-5472.CAN-04-1906
10.1016/j.bbaexp.2003.08.006
10.1073/pnas.93.24.13943
10.1002/ijc.22943
10.1101/gad.13.1.76
10.1074/jbc.M211898200
10.1016/j.mrfmmm.2005.04.017
10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9
10.1146/annurev.pharmtox.44.101802.121851
10.1073/pnas.051618798
10.1073/pnas.93.25.14960
10.1016/S0070-2137(01)80009-1
10.1016/j.mrfmmm.2004.06.041
10.1074/jbc.M211558200
10.1593/neo.04394
10.1006/bbrc.1997.6943
10.1200/JCO.2004.05.158
10.1158/0008-5472.CAN-05-3823
10.1073/pnas.0304146101
10.1084/jem.20050538
10.1016/j.humpath.2007.02.008
10.1016/S0006-2952(03)00083-2
10.1016/S1476-5586(04)80047-2
10.1158/0008-5472.CAN-04-2158
10.1016/j.bbrc.2006.10.102
10.1042/bj20020320
10.1016/S0891-5849(00)00306-3
10.1158/0008-5472.CAN-05-2020
10.1158/1078-0432.CCR-05-2072
10.1016/j.ccr.2005.10.001
ContentType Journal Article
Copyright Springer Nature Limited 2008
2008 INIST-CNRS
COPYRIGHT 2008 Nature Publishing Group
Copyright Nature Publishing Group Jul 17, 2008
Nature Publishing Group 2008.
Copyright_xml – notice: Springer Nature Limited 2008
– notice: 2008 INIST-CNRS
– notice: COPYRIGHT 2008 Nature Publishing Group
– notice: Copyright Nature Publishing Group Jul 17, 2008
– notice: Nature Publishing Group 2008.
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7TM
7TO
7U9
7X7
7XB
88A
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7P
MBDVC
P64
PQEST
PQQKQ
PQUKI
PRINS
Q9U
RC3
DOI 10.1038/onc.2008.79
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Medical Database
ProQuest research library
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
Technology Research Database
ProQuest Central Essentials
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList Research Library Prep
Research Library Prep
MEDLINE
Genetics Abstracts
Genetics Abstracts

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
EISSN 1476-5594
EndPage 4362
ExternalDocumentID 1512824721
A190794648
10_1038_onc_2008_79
18372916
20593586
onc200879
Genre Research Support, U.S. Gov't, Non-P.H.S
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: DK061488
– fundername: NIDDK NIH HHS
  grantid: 5T32 DK07758-05
– fundername: NCI NIH HHS
  grantid: 5T32 CA009674
GroupedDBID -
-Q-
0R
123
29N
2WC
39C
3O-
3V.
4.4
53G
5RE
70F
7X7
88A
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AADWK
AAPBV
AAWBL
AAYJO
AAZLF
ABAWZ
ABDBF
ABDEU
ABFLS
ABGIJ
ABPTK
ABUWG
ACGFS
ACKTT
ACPRK
ADBBV
ADHDB
ADQMX
AEDAW
AEJRE
AENEX
AEXYK
AFKRA
AFSHS
AGEZK
AHMBA
AHSBF
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B0M
BBAFP
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CAG
COF
CS3
DIK
DU5
DWQXO
E3Z
EAD
EAP
EBC
EBD
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EPL
ESX
F5P
FDQFY
FEDTE
FERAY
FIZPM
FRP
FSGXE
FYUFA
GNUQQ
GUQSH
HCIFZ
HVGLF
HZ
IAO
IHR
INH
INR
ITC
JSO
KQ8
L7B
LK8
M0L
M1P
M2O
M7P
N9A
NAO
O9-
OK1
OVD
P2P
PADUT
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
Q-
Q2X
RIG
RNS
RNT
RNTTT
SNX
SNYQT
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TSG
TUS
W2D
WH7
ZA5
---
0R~
36B
406
AANZL
ABAKF
ABJNI
ABLJU
ABZZP
ACAOD
ACGFO
ACMJI
ACRQY
ACZOJ
ADFRT
AEMSY
AEVLU
AFBBN
AGHAI
AGQEE
AILAN
ALIPV
AMYLF
CCPQU
DNIVK
DPUIP
EMOBN
HMCUK
HZ~
IWAJR
JZLTJ
NQJWS
NXXTH
SOHCF
SRMVM
UKHRP
~8M
.55
.GJ
08R
AATNV
AAUGY
AAYFA
ABEFU
ACBMV
ACBRV
ACBYP
ACIGE
ACTTH
ACVWB
ADMDM
ADYYL
AEFTE
AFFNX
AFNRJ
AGGBP
AJCLW
AJDOV
AMRJV
BAWUL
IQODW
NYICJ
TR2
UDS
X7M
ZXP
AAYZH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TM
7TO
7U9
7XB
8FD
8FK
FR3
H94
K9.
MBDVC
P64
Q9U
RC3
ID FETCH-LOGICAL-c665t-63e17d54af808f8ba0b469e15aed8ab8868048dae66edcb61ff45f4df03010d23
IEDL.DBID RNT
ISSN 0950-9232
IngestDate Fri Oct 25 05:51:28 EDT 2024
Fri Oct 25 12:17:52 EDT 2024
Thu Oct 10 19:09:09 EDT 2024
Tue Nov 19 05:06:52 EST 2024
Tue Nov 19 21:42:55 EST 2024
Tue Nov 12 23:44:01 EST 2024
Fri Sep 27 02:37:09 EDT 2024
Tue Oct 15 23:34:16 EDT 2024
Sun Oct 22 16:06:04 EDT 2023
Fri Oct 11 20:47:26 EDT 2024
Thu Oct 07 19:41:33 EDT 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 31
Keywords prostate cancer
tumorigenesis
Nrf2
DNA damage
oxidative stress
Oxidative stress
Urinary system disease
Prostate disease
Malignant tumor
Carcinogenesis
Free radical
DNA
Lesion
Transcription factor
Urogenital system
Male genital diseases
Prostate cancer
Prostate
Cancer
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c665t-63e17d54af808f8ba0b469e15aed8ab8868048dae66edcb61ff45f4df03010d23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1038/onc.2008.79
PMID 18372916
PQID 227357809
PQPubID 36330
PageCount 10
ParticipantIDs proquest_miscellaneous_21306637
proquest_miscellaneous_19748933
proquest_journals_2641385828
proquest_journals_227357809
gale_infotracmisc_A190794648
gale_infotracacademiconefile_A190794648
crossref_primary_10_1038_onc_2008_79
pubmed_primary_18372916
pascalfrancis_primary_20593586
springer_journals_10_1038_onc_2008_79
nature_primary_onc200879
ProviderPackageCode ABDEU
AEDAW
AAZLF
-Q-
AADWK
AAYJO
70F
ADQMX
EE.
RNTTT
SWTZT
ABGIJ
RNT
NAO
PublicationCentury 2000
PublicationDate 2008-07-17
PublicationDateYYYYMMDD 2008-07-17
PublicationDate_xml – month: 07
  year: 2008
  text: 2008-07-17
  day: 17
PublicationDecade 2000
PublicationPlace London
PublicationPlace_xml – name: London
– name: Basingstoke
– name: England
– name: New York
PublicationTitle Oncogene
PublicationTitleAbbrev Oncogene
PublicationTitleAlternate Oncogene
PublicationYear 2008
Publisher Nature Publishing Group UK
Nature Publishing
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing
– name: Nature Publishing Group
References Thimmulappa, RK, Scollick, C, Traore, K, Yates, M, Trush, MA, Liby, KT 2006; 351
Luo, J, Duggan, DJ, Chen, Y, Sauvageot, J, Ewing, CM, Bittner, ML 2001; 61
Osburn, WO, Karim, B, Dolan, PM, Liu, G, Yamamoto, M, Huso, DL 2007; 121
Ho, SM, Leung, YK, Chung, I 2006; 1089
Klaunig, JE, Kamendulis, LM 2004; 44
Itoh, K, Chiba, T, Takahashi, S, Ishii, T, Igarashi, K, Katoh, Y 1997; 236
Day, KC, McCabe, MT, Zhao, X, Wang, Y, Davis, JN, Phillips, J 2002; 277
Brooks, JD, Paton, VG, Vidanes, G 2001; 10
Kwak, MK, Wakabayashi, N, Kensler, TW 2004; 555
Baker, AM, Oberley, LW, Cohen, MB 1997; 32
McCabe, MT, Low, JA, Daignault, S, Imperiale, MJ, Wojno, KJ, Day, ML 2006; 66
Magee, JA, Araki, T, Patil, S, Ehrig, T, True, L, Humphrey, PA 2001; 61
Rangasamy, T, Guo, J, Mitzner, WA, Roman, J, Singh, A, Fryer, AD 2005; 202
McCabe, M, Azih, OJ, Day, ML 2005a; 7
Welsh, JB, Sapinoso, LM, Su, AI, Kern, SG, Wang-Rodriguez, J, Moskaluk, CA 2001; 61
Yu, YP, Landsittel, D, Jing, L, Nelson, J, Ren, B, Liu, L 2004; 22
Chanas, SA, Jiang, Q, McMahon, M, McWalter, GK, McLellan, LI, Elcombe, CR 2002; 365
De Marzo, AM, Platz, EA, Sutcliffe, S, Xu, J, Gronberg, H, Drake, CG 2007; 7
Dhakshinamoorthy, S, Long, DJ, Jaiswal, AK 2000; 36
Lee, JM, Calkins, MJ, Chan, K, Kan, YW, Johnson, JA 2003b; 278
Hayes, JD, Pulford, DJ 1995; 30
Vanaja, DK, Ballman, KV, Morlan, BW, Cheville, JC, Neumann, RM, Lieber, MM 2006; 12
Bostwick, DG, Meiers, I, Shanks, JH 2007; 38
Ouyang, X, DeWeese, TL, Nelson, WG, Abate-Shen, C 2005; 65
Arnold, RS, Shi, J, Murad, E, Whalen, AM, Sun, CQ, Polavarapu, R 2001; 98
Guyton, KZ, Kensler, TW 1993; 49
Jaiswal, AK 2000; 29
Lapointe, J, Li, C, Higgins, JP, van de Rijn, M, Bair, E, Montgomery, K 2004; 101
McCabe, MT, Davis, JN, Day, ML 2005b; 65
Varambally, S, Yu, J, Laxman, B, Rhodes, DR, Mehra, R, Tomlins, SA 2005; 8
Dhanasekaran, SM, Barrette, TR, Ghosh, D, Shah, R, Varambally, S, Kurachi, K 2001; 412
Iida, K, Itoh, K, Kumagai, Y, Oyasu, R, Hattori, K, Kawai, K 2004; 64
Wang, Y, Hayward, SW, Donjacour, AA, Young, P, Jacks, T, Sage, J 2000; 60
Rhodes, DR, Yu, J, Shanker, K, Deshpande, N, Varambally, R, Ghosh, D 2004; 6
LaTulippe, E, Satagopan, J, Smith, A, Scher, H, Scardino, P, Reuter, V 2002; 62
Myhre, O, Andersen, JM, Aarnes, H, Fonnum, F 2003; 65
Chan, K, Lu, R, Chang, JC, Kan, YW 1996; 93
Greenberg, NM, DeMayo, F, Finegold, MJ, Medina, D, Tilley, WD, Aspinall, JO 1995; 92
Bostwick, DG, Alexander, EE, Singh, R, Shan, A, Qian, J, Santella, RM 2000; 89
Tam, NN, Nyska, A, Maronpot, RR, Kissling, G, Lomnitski, L, Suttie, A 2006; 66
Hayes, JD, Flanagan, JU, Jowsey, IR 2004; 45
Ma, Q, Battelli, L, Hubbs, AF 2006; 168
Kwak, MK, Wakabayashi, N, Itoh, K, Motohashi, H, Yamamoto, M, Kensler, TW 2003; 278
Itoh, K, Wakabayashi, N, Katoh, Y, Ishii, T, Igarashi, K, Engel, JD 1999; 13
Yates, MS, Kwak, MK, Egner, PA, Groopman, JD, Bodreddigari, S, Sutter, TR 2006; 66
Venugopal, R, Jaiswal, AK 1996; 93
Lee, JM, Anderson, PC, Padgitt, JK, Hanson, JM, Waters, CM, Johnson, JA 2003a; 1629
Yu, X, Kensler, T 2005; 591
Zhu, M, Fahl, WE 2001; 289
Glinsky, GV, Glinskii, AB, Stephenson, AJ, Hoffman, RM, Gerald, WL 2004; 113
Ramos-Gomez, M, Kwak, MK, Dolan, PM, Itoh, K, Yamamoto, M, Talalay, P 2001; 98
McCabe, Azih, Day (CR32) 2005; 7
McCabe, Davis, Day (CR33) 2005; 65
Arnold, Shi, Murad, Whalen, Sun, Polavarapu (CR1) 2001; 98
Itoh, Wakabayashi, Katoh, Ishii, Igarashi, Engel (CR20) 1999; 13
Magee, Araki, Patil, Ehrig, True, Humphrey (CR31) 2001; 61
McCabe, Low, Daignault, Imperiale, Wojno, Day (CR34) 2006; 66
Rangasamy, Guo, Mitzner, Roman, Singh, Fryer (CR39) 2005; 202
Osburn, Karim, Dolan, Liu, Yamamoto, Huso (CR36) 2007; 121
Ouyang, DeWeese, Nelson, Abate-Shen (CR37) 2005; 65
Vanaja, Ballman, Morlan, Cheville, Neumann, Lieber (CR43) 2006; 12
Hayes, Pulford (CR16) 1995; 30
Greenberg, DeMayo, Finegold, Medina, Tilley, Aspinall (CR13) 1995; 92
Hayes, Flanagan, Jowsey (CR15) 2004; 45
Brooks, Paton, Vidanes (CR5) 2001; 10
Iida, Itoh, Kumagai, Oyasu, Hattori, Kawai (CR18) 2004; 64
De Marzo, Platz, Sutcliffe, Xu, Gronberg, Drake (CR9) 2007; 7
Ho, Leung, Chung (CR17) 2006; 1089
Klaunig, Kamendulis (CR22) 2004; 44
Jaiswal (CR21) 2000; 29
Venugopal, Jaiswal (CR45) 1996; 93
Lee, Anderson, Padgitt, Hanson, Waters, Johnson (CR27) 2003; 1629
Varambally, Yu, Laxman, Rhodes, Mehra, Tomlins (CR44) 2005; 8
Rhodes, Yu, Shanker, Deshpande, Varambally, Ghosh (CR40) 2004; 6
Yates, Kwak, Egner, Groopman, Bodreddigari, Sutter (CR48) 2006; 66
Kwak, Wakabayashi, Kensler (CR24) 2004; 555
Thimmulappa, Scollick, Traore, Yates, Trush, Liby (CR42) 2006; 351
Tam, Nyska, Maronpot, Kissling, Lomnitski, Suttie (CR41) 2006; 66
Wang, Hayward, Donjacour, Young, Jacks, Sage (CR46) 2000; 60
Welsh, Sapinoso, Su, Kern, Wang-Rodriguez, Moskaluk (CR47) 2001; 61
Day, McCabe, Zhao, Wang, Davis, Phillips (CR8) 2002; 277
Myhre, Andersen, Aarnes, Fonnum (CR35) 2003; 65
Ma, Battelli, Hubbs (CR30) 2006; 168
Ramos-Gomez, Kwak, Dolan, Itoh, Yamamoto, Talalay (CR38) 2001; 98
Guyton, Kensler (CR14) 1993; 49
Dhanasekaran, Barrette, Ghosh, Shah, Varambally, Kurachi (CR11) 2001; 412
LaTulippe, Satagopan, Smith, Scher, Scardino, Reuter (CR26) 2002; 62
Glinsky, Glinskii, Stephenson, Hoffman, Gerald (CR12) 2004; 113
Kwak, Wakabayashi, Itoh, Motohashi, Yamamoto, Kensler (CR23) 2003; 278
Chan, Lu, Chang, Kan (CR6) 1996; 93
Bostwick, Meiers, Shanks (CR4) 2007; 38
Luo, Duggan, Chen, Sauvageot, Ewing, Bittner (CR29) 2001; 61
Baker, Oberley, Cohen (CR2) 1997; 32
Chanas, Jiang, McMahon, McWalter, McLellan, Elcombe (CR7) 2002; 365
Lee, Calkins, Chan, Kan, Johnson (CR28) 2003; 278
Dhakshinamoorthy, Long, Jaiswal (CR10) 2000; 36
Yu, Kensler (CR49) 2005; 591
Zhu, Fahl (CR51) 2001; 289
Lapointe, Li, Higgins, van de Rijn, Bair, Montgomery (CR25) 2004; 101
Itoh, Chiba, Takahashi, Ishii, Igarashi, Katoh (CR19) 1997; 236
Yu, Landsittel, Jing, Nelson, Ren, Liu (CR50) 2004; 22
Bostwick, Alexander, Singh, Shan, Qian, Santella (CR3) 2000; 89
JB Welsh (BFonc200879_CR47) 2001; 61
NN Tam (BFonc200879_CR41) 2006; 66
SM Dhanasekaran (BFonc200879_CR11) 2001; 412
RK Thimmulappa (BFonc200879_CR42) 2006; 351
MT McCabe (BFonc200879_CR33) 2005; 65
K Iida (BFonc200879_CR18) 2004; 64
M McCabe (BFonc200879_CR32) 2005; 7
KC Day (BFonc200879_CR8) 2002; 277
K Chan (BFonc200879_CR6) 1996; 93
DK Vanaja (BFonc200879_CR43) 2006; 12
JD Brooks (BFonc200879_CR5) 2001; 10
MK Kwak (BFonc200879_CR23) 2003; 278
MS Yates (BFonc200879_CR48) 2006; 66
JD Hayes (BFonc200879_CR15) 2004; 45
R Venugopal (BFonc200879_CR45) 1996; 93
X Yu (BFonc200879_CR49) 2005; 591
T Rangasamy (BFonc200879_CR39) 2005; 202
NM Greenberg (BFonc200879_CR13) 1995; 92
AM Baker (BFonc200879_CR2) 1997; 32
SM Ho (BFonc200879_CR17) 2006; 1089
GV Glinsky (BFonc200879_CR12) 2004; 113
E LaTulippe (BFonc200879_CR26) 2002; 62
K Itoh (BFonc200879_CR19) 1997; 236
DR Rhodes (BFonc200879_CR40) 2004; 6
O Myhre (BFonc200879_CR35) 2003; 65
WO Osburn (BFonc200879_CR36) 2007; 121
KZ Guyton (BFonc200879_CR14) 1993; 49
JM Lee (BFonc200879_CR28) 2003; 278
J Lapointe (BFonc200879_CR25) 2004; 101
MK Kwak (BFonc200879_CR24) 2004; 555
MT McCabe (BFonc200879_CR34) 2006; 66
JE Klaunig (BFonc200879_CR22) 2004; 44
YP Yu (BFonc200879_CR50) 2004; 22
Q Ma (BFonc200879_CR30) 2006; 168
JM Lee (BFonc200879_CR27) 2003; 1629
X Ouyang (BFonc200879_CR37) 2005; 65
J Luo (BFonc200879_CR29) 2001; 61
DG Bostwick (BFonc200879_CR4) 2007; 38
S Varambally (BFonc200879_CR44) 2005; 8
Y Wang (BFonc200879_CR46) 2000; 60
SA Chanas (BFonc200879_CR7) 2002; 365
AK Jaiswal (BFonc200879_CR21) 2000; 29
M Ramos-Gomez (BFonc200879_CR38) 2001; 98
AM De Marzo (BFonc200879_CR9) 2007; 7
JD Hayes (BFonc200879_CR16) 1995; 30
K Itoh (BFonc200879_CR20) 1999; 13
RS Arnold (BFonc200879_CR1) 2001; 98
S Dhakshinamoorthy (BFonc200879_CR10) 2000; 36
JA Magee (BFonc200879_CR31) 2001; 61
DG Bostwick (BFonc200879_CR3) 2000; 89
M Zhu (BFonc200879_CR51) 2001; 289
References_xml – volume: 277
  start-page: 44475
  year: 2002
  end-page: 44484
  article-title: Rescue of embryonic epithelium reveals that the homozygous deletion of the retinoblastoma gene confers growth factor independence and immortality but does not influence epithelial differentiation or tissue morphogenesis
  publication-title: J Biol Chem
  contributor:
    fullname: Phillips, J
– volume: 93
  start-page: 13943
  year: 1996
  end-page: 13948
  article-title: NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Kan, YW
– volume: 64
  start-page: 6424
  year: 2004
  end-page: 6431
  article-title: Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis
  publication-title: Cancer Res
  contributor:
    fullname: Kawai, K
– volume: 89
  start-page: 123
  year: 2000
  end-page: 134
  article-title: Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer
  publication-title: Cancer
  contributor:
    fullname: Santella, RM
– volume: 61
  start-page: 4683
  year: 2001
  end-page: 4688
  article-title: Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling
  publication-title: Cancer Res
  contributor:
    fullname: Bittner, ML
– volume: 351
  start-page: 883
  year: 2006
  end-page: 889
  article-title: Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide
  publication-title: Biochem Biophys Res Commun
  contributor:
    fullname: Liby, KT
– volume: 12
  start-page: 1128
  year: 2006
  end-page: 1136
  article-title: PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer
  publication-title: Clin Cancer Res
  contributor:
    fullname: Lieber, MM
– volume: 61
  start-page: 5692
  year: 2001
  end-page: 5696
  article-title: Expression profiling reveals hepsin overexpression in prostate cancer
  publication-title: Cancer Res
  contributor:
    fullname: Humphrey, PA
– volume: 13
  start-page: 76
  year: 1999
  end-page: 86
  article-title: Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain
  publication-title: Genes Dev
  contributor:
    fullname: Engel, JD
– volume: 66
  start-page: 2488
  year: 2006
  end-page: 2494
  article-title: Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole
  publication-title: Cancer Res
  contributor:
    fullname: Sutter, TR
– volume: 278
  start-page: 12029
  year: 2003b
  end-page: 12038
  article-title: Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis
  publication-title: J Biol Chem
  contributor:
    fullname: Johnson, JA
– volume: 289
  start-page: 212
  year: 2001
  end-page: 219
  article-title: Functional characterization of transcription regulators that interact with the electrophile response element
  publication-title: Biochem Biophys Res Commun
  contributor:
    fullname: Fahl, WE
– volume: 65
  start-page: 3624
  year: 2005b
  end-page: 3632
  article-title: Regulation of DNA methyltransferase 1 by the pRb E2F1 pathway
  publication-title: Cancer Res
  contributor:
    fullname: Day, ML
– volume: 65
  start-page: 6773
  year: 2005
  end-page: 6779
  article-title: Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis
  publication-title: Cancer Res
  contributor:
    fullname: Abate-Shen, C
– volume: 65
  start-page: 1575
  year: 2003
  end-page: 1582
  article-title: Evaluation of the probes 2′,7′-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation
  publication-title: Biochem Pharmacol
  contributor:
    fullname: Fonnum, F
– volume: 8
  start-page: 393
  year: 2005
  end-page: 406
  article-title: Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
  publication-title: Cancer Cell
  contributor:
    fullname: Tomlins, SA
– volume: 36
  start-page: 201
  year: 2000
  end-page: 216
  article-title: Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens
  publication-title: Curr Top Cell Regul
  contributor:
    fullname: Jaiswal, AK
– volume: 1089
  start-page: 177
  year: 2006
  end-page: 193
  article-title: Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer
  publication-title: Ann N Y Acad Sci
  contributor:
    fullname: Chung, I
– volume: 66
  start-page: 385
  year: 2006
  end-page: 392
  article-title: Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer
  publication-title: Cancer Res
  contributor:
    fullname: Day, ML
– volume: 555
  start-page: 133
  year: 2004
  end-page: 148
  article-title: Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers
  publication-title: Mutat Res
  contributor:
    fullname: Kensler, TW
– volume: 44
  start-page: 239
  year: 2004
  end-page: 267
  article-title: The role of oxidative stress in carcinogenesis
  publication-title: Annu Rev Pharmacol Toxicol
  contributor:
    fullname: Kamendulis, LM
– volume: 45
  start-page: 51
  year: 2004
  end-page: 88
  article-title: Glutathione transferases
  publication-title: Annu Rev Pharmacol Toxicol
  contributor:
    fullname: Jowsey, IR
– volume: 236
  start-page: 313
  year: 1997
  end-page: 322
  article-title: An Nrf2 small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements
  publication-title: Biochem Biophys Res Commun
  contributor:
    fullname: Katoh, Y
– volume: 10
  start-page: 949
  year: 2001
  end-page: 954
  article-title: Potent induction of phase 2 enzymes in human prostate cells by sulforaphane
  publication-title: Cancer Epidemiol Biomarkers Prev
  contributor:
    fullname: Vidanes, G
– volume: 32
  start-page: 229
  year: 1997
  end-page: 233
  article-title: Expression of antioxidant enzymes in human prostatic adenocarcinoma
  publication-title: Prostate
  contributor:
    fullname: Cohen, MB
– volume: 93
  start-page: 14960
  year: 1996
  end-page: 14965
  article-title: Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Jaiswal, AK
– volume: 92
  start-page: 3439
  year: 1995
  end-page: 3443
  article-title: Prostate cancer in a transgenic mouse
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Aspinall, JO
– volume: 113
  start-page: 913
  year: 2004
  end-page: 923
  article-title: Gene expression profiling predicts clinical outcome of prostate cancer
  publication-title: J Clin Invest
  contributor:
    fullname: Gerald, WL
– volume: 7
  start-page: 256
  year: 2007
  end-page: 269
  article-title: Inflammation in prostate carcinogenesis
  publication-title: Nat Rev Cancer
  contributor:
    fullname: Drake, CG
– volume: 365
  start-page: 405
  year: 2002
  end-page: 416
  article-title: Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice
  publication-title: Biochem J
  contributor:
    fullname: Elcombe, CR
– volume: 22
  start-page: 2790
  year: 2004
  end-page: 2799
  article-title: Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy
  publication-title: J Clin Oncol
  contributor:
    fullname: Liu, L
– volume: 7
  start-page: 141
  year: 2005a
  end-page: 151
  article-title: pRb-independent growth arrest and transcriptional regulation of E2F target genes
  publication-title: Neoplasia
  contributor:
    fullname: Day, ML
– volume: 98
  start-page: 5550
  year: 2001
  end-page: 5555
  article-title: Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Polavarapu, R
– volume: 29
  start-page: 254
  year: 2000
  end-page: 262
  article-title: Regulation of genes encoding NAD(P)H:quinone oxidoreductases
  publication-title: Free Radic Biol Med
  contributor:
    fullname: Jaiswal, AK
– volume: 1629
  start-page: 92
  year: 2003a
  end-page: 101
  article-title: Nrf2, not the estrogen receptor, mediates catechol estrogen-induced activation of the antioxidant responsive element
  publication-title: Biochim Biophys Acta
  contributor:
    fullname: Johnson, JA
– volume: 98
  start-page: 3410
  year: 2001
  end-page: 3415
  article-title: Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Talalay, P
– volume: 121
  start-page: 1883
  year: 2007
  end-page: 1891
  article-title: Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment
  publication-title: Int J Cancer
  contributor:
    fullname: Huso, DL
– volume: 278
  start-page: 8135
  year: 2003
  end-page: 8145
  article-title: Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival
  publication-title: J Biol Chem
  contributor:
    fullname: Kensler, TW
– volume: 168
  start-page: 1960
  year: 2006
  end-page: 1974
  article-title: Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2
  publication-title: Am J Pathol
  contributor:
    fullname: Hubbs, AF
– volume: 101
  start-page: 811
  year: 2004
  end-page: 816
  article-title: Gene expression profiling identifies clinically relevant subtypes of prostate cancer
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Montgomery, K
– volume: 62
  start-page: 4499
  year: 2002
  end-page: 4506
  article-title: Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease
  publication-title: Cancer Res
  contributor:
    fullname: Reuter, V
– volume: 202
  start-page: 47
  year: 2005
  end-page: 59
  article-title: Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice
  publication-title: J Exp Med
  contributor:
    fullname: Fryer, AD
– volume: 60
  start-page: 6008
  year: 2000
  end-page: 6017
  article-title: Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue
  publication-title: Cancer Res
  contributor:
    fullname: Sage, J
– volume: 61
  start-page: 5974
  year: 2001
  end-page: 5978
  article-title: Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer
  publication-title: Cancer Res
  contributor:
    fullname: Moskaluk, CA
– volume: 38
  start-page: 1394
  year: 2007
  end-page: 1401
  article-title: Glutathione S-transferase: differential expression of alpha, mu, and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma
  publication-title: Hum Pathol
  contributor:
    fullname: Shanks, JH
– volume: 591
  start-page: 93
  year: 2005
  end-page: 102
  article-title: Nrf2 as a target for cancer chemoprevention
  publication-title: Mutat Res
  contributor:
    fullname: Kensler, T
– volume: 412
  start-page: 822
  year: 2001
  end-page: 826
  article-title: Delineation of prognostic biomarkers in prostate cancer
  publication-title: Nature
  contributor:
    fullname: Kurachi, K
– volume: 66
  start-page: 57
  year: 2006
  end-page: 69
  article-title: Differential attenuation of oxidative nitrosative injuries in early prostatic neoplastic lesions in TRAMP mice by dietary antioxidants
  publication-title: Prostate
  contributor:
    fullname: Suttie, A
– volume: 6
  start-page: 1
  year: 2004
  end-page: 6
  article-title: ONCOMINE: a cancer microarray database and integrated data-mining platform
  publication-title: Neoplasia
  contributor:
    fullname: Ghosh, D
– volume: 49
  start-page: 523
  year: 1993
  end-page: 544
  article-title: Oxidative mechanisms in carcinogenesis
  publication-title: Br Med Bull
  contributor:
    fullname: Kensler, TW
– volume: 30
  start-page: 445
  year: 1995
  end-page: 600
  article-title: The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance
  publication-title: Crit Rev Biochem Mol Biol
  contributor:
    fullname: Pulford, DJ
– volume: 30
  start-page: 445
  year: 1995
  end-page: 600
  ident: CR16
  article-title: The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance
  publication-title: Crit Rev Biochem Mol Biol
  doi: 10.3109/10409239509083491
  contributor:
    fullname: Pulford
– volume: 168
  start-page: 1960
  year: 2006
  end-page: 1974
  ident: CR30
  article-title: Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2006.051113
  contributor:
    fullname: Hubbs
– volume: 66
  start-page: 57
  year: 2006
  end-page: 69
  ident: CR41
  article-title: Differential attenuation of oxidative/nitrosative injuries in early prostatic neoplastic lesions in TRAMP mice by dietary antioxidants
  publication-title: Prostate
  doi: 10.1002/pros.20313
  contributor:
    fullname: Suttie
– volume: 113
  start-page: 913
  year: 2004
  end-page: 923
  ident: CR12
  article-title: Gene expression profiling predicts clinical outcome of prostate cancer
  publication-title: J Clin Invest
  doi: 10.1172/JCI20032
  contributor:
    fullname: Gerald
– volume: 1089
  start-page: 177
  year: 2006
  end-page: 193
  ident: CR17
  article-title: Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer
  publication-title: Ann N Y Acad Sci
  doi: 10.1196/annals.1386.005
  contributor:
    fullname: Chung
– volume: 289
  start-page: 212
  year: 2001
  end-page: 219
  ident: CR51
  article-title: Functional characterization of transcription regulators that interact with the electrophile response element
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.2001.5944
  contributor:
    fullname: Fahl
– volume: 61
  start-page: 4683
  year: 2001
  end-page: 4688
  ident: CR29
  article-title: Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling
  publication-title: Cancer Res
  contributor:
    fullname: Bittner
– volume: 65
  start-page: 6773
  year: 2005
  end-page: 6779
  ident: CR37
  article-title: Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-1948
  contributor:
    fullname: Abate-Shen
– volume: 60
  start-page: 6008
  year: 2000
  end-page: 6017
  ident: CR46
  article-title: Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue
  publication-title: Cancer Res
  contributor:
    fullname: Sage
– volume: 277
  start-page: 44475
  year: 2002
  end-page: 44484
  ident: CR8
  article-title: Rescue of embryonic epithelium reveals that the homozygous deletion of the retinoblastoma gene confers growth factor independence and immortality but does not influence epithelial differentiation or tissue morphogenesis
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M205361200
  contributor:
    fullname: Phillips
– volume: 92
  start-page: 3439
  year: 1995
  end-page: 3443
  ident: CR13
  article-title: Prostate cancer in a transgenic mouse
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.92.8.3439
  contributor:
    fullname: Aspinall
– volume: 45
  start-page: 51
  year: 2004
  end-page: 88
  ident: CR15
  article-title: Glutathione transferases
  publication-title: Annu Rev Pharmacol Toxicol
  doi: 10.1146/annurev.pharmtox.45.120403.095857
  contributor:
    fullname: Jowsey
– volume: 98
  start-page: 5550
  year: 2001
  end-page: 5555
  ident: CR1
  article-title: Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.101505898
  contributor:
    fullname: Polavarapu
– volume: 32
  start-page: 229
  year: 1997
  end-page: 233
  ident: CR2
  article-title: Expression of antioxidant enzymes in human prostatic adenocarcinoma
  publication-title: Prostate
  doi: 10.1002/(SICI)1097-0045(19970901)32:4<229::AID-PROS1>3.0.CO;2-E
  contributor:
    fullname: Cohen
– volume: 49
  start-page: 523
  year: 1993
  end-page: 544
  ident: CR14
  article-title: Oxidative mechanisms in carcinogenesis
  publication-title: Br Med Bull
  doi: 10.1093/oxfordjournals.bmb.a072628
  contributor:
    fullname: Kensler
– volume: 7
  start-page: 256
  year: 2007
  end-page: 269
  ident: CR9
  article-title: Inflammation in prostate carcinogenesis
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2090
  contributor:
    fullname: Drake
– volume: 412
  start-page: 822
  year: 2001
  end-page: 826
  ident: CR11
  article-title: Delineation of prognostic biomarkers in prostate cancer
  publication-title: Nature
  doi: 10.1038/35090585
  contributor:
    fullname: Kurachi
– volume: 64
  start-page: 6424
  year: 2004
  end-page: 6431
  ident: CR18
  article-title: Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-04-1906
  contributor:
    fullname: Kawai
– volume: 62
  start-page: 4499
  year: 2002
  end-page: 4506
  ident: CR26
  article-title: Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease
  publication-title: Cancer Res
  contributor:
    fullname: Reuter
– volume: 1629
  start-page: 92
  year: 2003
  end-page: 101
  ident: CR27
  article-title: Nrf2, not the estrogen receptor, mediates catechol estrogen-induced activation of the antioxidant responsive element
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbaexp.2003.08.006
  contributor:
    fullname: Johnson
– volume: 93
  start-page: 13943
  year: 1996
  end-page: 13948
  ident: CR6
  article-title: NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.93.24.13943
  contributor:
    fullname: Kan
– volume: 121
  start-page: 1883
  year: 2007
  end-page: 1891
  ident: CR36
  article-title: Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment
  publication-title: Int J Cancer
  doi: 10.1002/ijc.22943
  contributor:
    fullname: Huso
– volume: 61
  start-page: 5974
  year: 2001
  end-page: 5978
  ident: CR47
  article-title: Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer
  publication-title: Cancer Res
  contributor:
    fullname: Moskaluk
– volume: 13
  start-page: 76
  year: 1999
  end-page: 86
  ident: CR20
  article-title: Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain
  publication-title: Genes Dev
  doi: 10.1101/gad.13.1.76
  contributor:
    fullname: Engel
– volume: 278
  start-page: 8135
  year: 2003
  end-page: 8145
  ident: CR23
  article-title: Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M211898200
  contributor:
    fullname: Kensler
– volume: 591
  start-page: 93
  year: 2005
  end-page: 102
  ident: CR49
  article-title: Nrf2 as a target for cancer chemoprevention
  publication-title: Mutat Res
  doi: 10.1016/j.mrfmmm.2005.04.017
  contributor:
    fullname: Kensler
– volume: 89
  start-page: 123
  year: 2000
  end-page: 134
  ident: CR3
  article-title: Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer
  publication-title: Cancer
  doi: 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9
  contributor:
    fullname: Santella
– volume: 44
  start-page: 239
  year: 2004
  end-page: 267
  ident: CR22
  article-title: The role of oxidative stress in carcinogenesis
  publication-title: Annu Rev Pharmacol Toxicol
  doi: 10.1146/annurev.pharmtox.44.101802.121851
  contributor:
    fullname: Kamendulis
– volume: 98
  start-page: 3410
  year: 2001
  end-page: 3415
  ident: CR38
  article-title: Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.051618798
  contributor:
    fullname: Talalay
– volume: 93
  start-page: 14960
  year: 1996
  end-page: 14965
  ident: CR45
  article-title: Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.93.25.14960
  contributor:
    fullname: Jaiswal
– volume: 36
  start-page: 201
  year: 2000
  end-page: 216
  ident: CR10
  article-title: Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens
  publication-title: Curr Top Cell Regul
  doi: 10.1016/S0070-2137(01)80009-1
  contributor:
    fullname: Jaiswal
– volume: 555
  start-page: 133
  year: 2004
  end-page: 148
  ident: CR24
  article-title: Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers
  publication-title: Mutat Res
  doi: 10.1016/j.mrfmmm.2004.06.041
  contributor:
    fullname: Kensler
– volume: 278
  start-page: 12029
  year: 2003
  end-page: 12038
  ident: CR28
  article-title: Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M211558200
  contributor:
    fullname: Johnson
– volume: 7
  start-page: 141
  year: 2005
  end-page: 151
  ident: CR32
  article-title: pRb-independent growth arrest and transcriptional regulation of E2F target genes
  publication-title: Neoplasia
  doi: 10.1593/neo.04394
  contributor:
    fullname: Day
– volume: 236
  start-page: 313
  year: 1997
  end-page: 322
  ident: CR19
  article-title: An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.1997.6943
  contributor:
    fullname: Katoh
– volume: 61
  start-page: 5692
  year: 2001
  end-page: 5696
  ident: CR31
  article-title: Expression profiling reveals hepsin overexpression in prostate cancer
  publication-title: Cancer Res
  contributor:
    fullname: Humphrey
– volume: 22
  start-page: 2790
  year: 2004
  end-page: 2799
  ident: CR50
  article-title: Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2004.05.158
  contributor:
    fullname: Liu
– volume: 66
  start-page: 2488
  year: 2006
  end-page: 2494
  ident: CR48
  article-title: Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-3823
  contributor:
    fullname: Sutter
– volume: 101
  start-page: 811
  year: 2004
  end-page: 816
  ident: CR25
  article-title: Gene expression profiling identifies clinically relevant subtypes of prostate cancer
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0304146101
  contributor:
    fullname: Montgomery
– volume: 10
  start-page: 949
  year: 2001
  end-page: 954
  ident: CR5
  article-title: Potent induction of phase 2 enzymes in human prostate cells by sulforaphane
  publication-title: Cancer Epidemiol Biomarkers Prev
  contributor:
    fullname: Vidanes
– volume: 202
  start-page: 47
  year: 2005
  end-page: 59
  ident: CR39
  article-title: Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice
  publication-title: J Exp Med
  doi: 10.1084/jem.20050538
  contributor:
    fullname: Fryer
– volume: 38
  start-page: 1394
  year: 2007
  end-page: 1401
  ident: CR4
  article-title: Glutathione S-transferase: differential expression of alpha, mu, and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2007.02.008
  contributor:
    fullname: Shanks
– volume: 65
  start-page: 1575
  year: 2003
  end-page: 1582
  ident: CR35
  article-title: Evaluation of the probes 2′,7′-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation
  publication-title: Biochem Pharmacol
  doi: 10.1016/S0006-2952(03)00083-2
  contributor:
    fullname: Fonnum
– volume: 6
  start-page: 1
  year: 2004
  end-page: 6
  ident: CR40
  article-title: ONCOMINE: a cancer microarray database and integrated data-mining platform
  publication-title: Neoplasia
  doi: 10.1016/S1476-5586(04)80047-2
  contributor:
    fullname: Ghosh
– volume: 65
  start-page: 3624
  year: 2005
  end-page: 3632
  ident: CR33
  article-title: Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-04-2158
  contributor:
    fullname: Day
– volume: 351
  start-page: 883
  year: 2006
  end-page: 889
  ident: CR42
  article-title: Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2006.10.102
  contributor:
    fullname: Liby
– volume: 365
  start-page: 405
  year: 2002
  end-page: 416
  ident: CR7
  article-title: Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice
  publication-title: Biochem J
  doi: 10.1042/bj20020320
  contributor:
    fullname: Elcombe
– volume: 29
  start-page: 254
  year: 2000
  end-page: 262
  ident: CR21
  article-title: Regulation of genes encoding NAD(P)H:quinone oxidoreductases
  publication-title: Free Radic Biol Med
  doi: 10.1016/S0891-5849(00)00306-3
  contributor:
    fullname: Jaiswal
– volume: 66
  start-page: 385
  year: 2006
  end-page: 392
  ident: CR34
  article-title: Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-2020
  contributor:
    fullname: Day
– volume: 12
  start-page: 1128
  year: 2006
  end-page: 1136
  ident: CR43
  article-title: PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-05-2072
  contributor:
    fullname: Lieber
– volume: 8
  start-page: 393
  year: 2005
  end-page: 406
  ident: CR44
  article-title: Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2005.10.001
  contributor:
    fullname: Tomlins
– volume: 22
  start-page: 2790
  year: 2004
  ident: BFonc200879_CR50
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2004.05.158
  contributor:
    fullname: YP Yu
– volume: 92
  start-page: 3439
  year: 1995
  ident: BFonc200879_CR13
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.92.8.3439
  contributor:
    fullname: NM Greenberg
– volume: 66
  start-page: 385
  year: 2006
  ident: BFonc200879_CR34
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-2020
  contributor:
    fullname: MT McCabe
– volume: 66
  start-page: 57
  year: 2006
  ident: BFonc200879_CR41
  publication-title: Prostate
  doi: 10.1002/pros.20313
  contributor:
    fullname: NN Tam
– volume: 36
  start-page: 201
  year: 2000
  ident: BFonc200879_CR10
  publication-title: Curr Top Cell Regul
  doi: 10.1016/S0070-2137(01)80009-1
  contributor:
    fullname: S Dhakshinamoorthy
– volume: 44
  start-page: 239
  year: 2004
  ident: BFonc200879_CR22
  publication-title: Annu Rev Pharmacol Toxicol
  doi: 10.1146/annurev.pharmtox.44.101802.121851
  contributor:
    fullname: JE Klaunig
– volume: 89
  start-page: 123
  year: 2000
  ident: BFonc200879_CR3
  publication-title: Cancer
  doi: 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9
  contributor:
    fullname: DG Bostwick
– volume: 7
  start-page: 141
  year: 2005
  ident: BFonc200879_CR32
  publication-title: Neoplasia
  doi: 10.1593/neo.04394
  contributor:
    fullname: M McCabe
– volume: 1089
  start-page: 177
  year: 2006
  ident: BFonc200879_CR17
  publication-title: Ann N Y Acad Sci
  doi: 10.1196/annals.1386.005
  contributor:
    fullname: SM Ho
– volume: 61
  start-page: 5692
  year: 2001
  ident: BFonc200879_CR31
  publication-title: Cancer Res
  contributor:
    fullname: JA Magee
– volume: 98
  start-page: 3410
  year: 2001
  ident: BFonc200879_CR38
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.051618798
  contributor:
    fullname: M Ramos-Gomez
– volume: 591
  start-page: 93
  year: 2005
  ident: BFonc200879_CR49
  publication-title: Mutat Res
  doi: 10.1016/j.mrfmmm.2005.04.017
  contributor:
    fullname: X Yu
– volume: 32
  start-page: 229
  year: 1997
  ident: BFonc200879_CR2
  publication-title: Prostate
  doi: 10.1002/(SICI)1097-0045(19970901)32:4<229::AID-PROS1>3.0.CO;2-E
  contributor:
    fullname: AM Baker
– volume: 12
  start-page: 1128
  year: 2006
  ident: BFonc200879_CR43
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-05-2072
  contributor:
    fullname: DK Vanaja
– volume: 278
  start-page: 12029
  year: 2003
  ident: BFonc200879_CR28
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M211558200
  contributor:
    fullname: JM Lee
– volume: 30
  start-page: 445
  year: 1995
  ident: BFonc200879_CR16
  publication-title: Crit Rev Biochem Mol Biol
  doi: 10.3109/10409239509083491
  contributor:
    fullname: JD Hayes
– volume: 236
  start-page: 313
  year: 1997
  ident: BFonc200879_CR19
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.1997.6943
  contributor:
    fullname: K Itoh
– volume: 61
  start-page: 5974
  year: 2001
  ident: BFonc200879_CR47
  publication-title: Cancer Res
  contributor:
    fullname: JB Welsh
– volume: 365
  start-page: 405
  year: 2002
  ident: BFonc200879_CR7
  publication-title: Biochem J
  doi: 10.1042/bj20020320
  contributor:
    fullname: SA Chanas
– volume: 38
  start-page: 1394
  year: 2007
  ident: BFonc200879_CR4
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2007.02.008
  contributor:
    fullname: DG Bostwick
– volume: 65
  start-page: 3624
  year: 2005
  ident: BFonc200879_CR33
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-04-2158
  contributor:
    fullname: MT McCabe
– volume: 8
  start-page: 393
  year: 2005
  ident: BFonc200879_CR44
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2005.10.001
  contributor:
    fullname: S Varambally
– volume: 64
  start-page: 6424
  year: 2004
  ident: BFonc200879_CR18
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-04-1906
  contributor:
    fullname: K Iida
– volume: 65
  start-page: 6773
  year: 2005
  ident: BFonc200879_CR37
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-1948
  contributor:
    fullname: X Ouyang
– volume: 412
  start-page: 822
  year: 2001
  ident: BFonc200879_CR11
  publication-title: Nature
  doi: 10.1038/35090585
  contributor:
    fullname: SM Dhanasekaran
– volume: 113
  start-page: 913
  year: 2004
  ident: BFonc200879_CR12
  publication-title: J Clin Invest
  doi: 10.1172/JCI20032
  contributor:
    fullname: GV Glinsky
– volume: 1629
  start-page: 92
  year: 2003
  ident: BFonc200879_CR27
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbaexp.2003.08.006
  contributor:
    fullname: JM Lee
– volume: 93
  start-page: 14960
  year: 1996
  ident: BFonc200879_CR45
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.93.25.14960
  contributor:
    fullname: R Venugopal
– volume: 29
  start-page: 254
  year: 2000
  ident: BFonc200879_CR21
  publication-title: Free Radic Biol Med
  doi: 10.1016/S0891-5849(00)00306-3
  contributor:
    fullname: AK Jaiswal
– volume: 98
  start-page: 5550
  year: 2001
  ident: BFonc200879_CR1
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.101505898
  contributor:
    fullname: RS Arnold
– volume: 351
  start-page: 883
  year: 2006
  ident: BFonc200879_CR42
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2006.10.102
  contributor:
    fullname: RK Thimmulappa
– volume: 101
  start-page: 811
  year: 2004
  ident: BFonc200879_CR25
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0304146101
  contributor:
    fullname: J Lapointe
– volume: 13
  start-page: 76
  year: 1999
  ident: BFonc200879_CR20
  publication-title: Genes Dev
  doi: 10.1101/gad.13.1.76
  contributor:
    fullname: K Itoh
– volume: 7
  start-page: 256
  year: 2007
  ident: BFonc200879_CR9
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2090
  contributor:
    fullname: AM De Marzo
– volume: 93
  start-page: 13943
  year: 1996
  ident: BFonc200879_CR6
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.93.24.13943
  contributor:
    fullname: K Chan
– volume: 121
  start-page: 1883
  year: 2007
  ident: BFonc200879_CR36
  publication-title: Int J Cancer
  doi: 10.1002/ijc.22943
  contributor:
    fullname: WO Osburn
– volume: 277
  start-page: 44475
  year: 2002
  ident: BFonc200879_CR8
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M205361200
  contributor:
    fullname: KC Day
– volume: 49
  start-page: 523
  year: 1993
  ident: BFonc200879_CR14
  publication-title: Br Med Bull
  doi: 10.1093/oxfordjournals.bmb.a072628
  contributor:
    fullname: KZ Guyton
– volume: 45
  start-page: 51
  year: 2004
  ident: BFonc200879_CR15
  publication-title: Annu Rev Pharmacol Toxicol
  doi: 10.1146/annurev.pharmtox.45.120403.095857
  contributor:
    fullname: JD Hayes
– volume: 10
  start-page: 949
  year: 2001
  ident: BFonc200879_CR5
  publication-title: Cancer Epidemiol Biomarkers Prev
  contributor:
    fullname: JD Brooks
– volume: 65
  start-page: 1575
  year: 2003
  ident: BFonc200879_CR35
  publication-title: Biochem Pharmacol
  doi: 10.1016/S0006-2952(03)00083-2
  contributor:
    fullname: O Myhre
– volume: 168
  start-page: 1960
  year: 2006
  ident: BFonc200879_CR30
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2006.051113
  contributor:
    fullname: Q Ma
– volume: 62
  start-page: 4499
  year: 2002
  ident: BFonc200879_CR26
  publication-title: Cancer Res
  contributor:
    fullname: E LaTulippe
– volume: 6
  start-page: 1
  year: 2004
  ident: BFonc200879_CR40
  publication-title: Neoplasia
  doi: 10.1016/S1476-5586(04)80047-2
  contributor:
    fullname: DR Rhodes
– volume: 278
  start-page: 8135
  year: 2003
  ident: BFonc200879_CR23
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M211898200
  contributor:
    fullname: MK Kwak
– volume: 60
  start-page: 6008
  year: 2000
  ident: BFonc200879_CR46
  publication-title: Cancer Res
  contributor:
    fullname: Y Wang
– volume: 61
  start-page: 4683
  year: 2001
  ident: BFonc200879_CR29
  publication-title: Cancer Res
  contributor:
    fullname: J Luo
– volume: 555
  start-page: 133
  year: 2004
  ident: BFonc200879_CR24
  publication-title: Mutat Res
  doi: 10.1016/j.mrfmmm.2004.06.041
  contributor:
    fullname: MK Kwak
– volume: 66
  start-page: 2488
  year: 2006
  ident: BFonc200879_CR48
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-3823
  contributor:
    fullname: MS Yates
– volume: 289
  start-page: 212
  year: 2001
  ident: BFonc200879_CR51
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.2001.5944
  contributor:
    fullname: M Zhu
– volume: 202
  start-page: 47
  year: 2005
  ident: BFonc200879_CR39
  publication-title: J Exp Med
  doi: 10.1084/jem.20050538
  contributor:
    fullname: T Rangasamy
SSID ssj0007902
Score 2.398505
Snippet The impact of oxidative stress in human cancer has been extensively studied. It is accepted that elevated reactive oxygen species (ROS) promote mutagenic DNA...
SourceID proquest
gale
crossref
pubmed
pascalfrancis
springer
nature
SourceType Aggregation Database
Index Database
Publisher
StartPage 4353
SubjectTerms Animal models
Animals
Antioxidants
Apoptosis
Biological and medical sciences
Cell Biology
Cell physiology
Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes
Cell Transformation, Neoplastic
Deoxyribonucleic acid
Detoxification
DNA
DNA binding proteins
DNA Damage
DNA microarrays
Enzymes
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation, Neoplastic
Genetic aspects
Genetic transformation
Genetics
Glutathione
Glutathione transferase
Glutathione Transferase - metabolism
Gynecology. Andrology. Obstetrics
Health aspects
Human Genetics
Humans
Internal Medicine
Leucine zipper proteins
Male
Male genital diseases
Medical sciences
Medicine
Medicine & Public Health
Mice
Mice, Knockout
Molecular and cellular biology
Nephrology. Urinary tract diseases
NF-E2-Related Factor 2 - metabolism
Oligonucleotide Array Sequence Analysis
Oncology
original-article
Oxidation
Oxidative stress
Physiological aspects
Prostate cancer
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - pathology
Reactive Oxygen Species
Retinoblastoma Protein - metabolism
Risk factors
Tumorigenesis
Tumors
Tumors of the urinary system
Urinary tract. Prostate gland
Title The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis
URI http://dx.doi.org/10.1038/onc.2008.79
https://link.springer.com/article/10.1038/onc.2008.79
https://www.ncbi.nlm.nih.gov/pubmed/18372916
https://www.proquest.com/docview/227357809
https://www.proquest.com/docview/2641385828
https://search.proquest.com/docview/19748933
https://search.proquest.com/docview/21306637
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swED-2jn3A2Ee2rl6zTA8tezKzLVuSH0PT0pflZR20LzOyJUEfaoc4gfa_353luGRLYGDIgySfcjqdf8d9AZxoiQqvjNOwEhwNFMlFmEvrQoSyzpQRT01OucOXP-X8Ws3OqUzO6R4PPlffm7ryIY-yS9OTvMvSml8N-lb6yELEClGIcCXps_D-Wrv13em171A88_VCt8gS53tZ7AKb_zhKu-_Pxdv_3Pk7eNMDTDb1EvEenth6BM99y8mHEbw823R4G8GLH71j_QP8RnFhFGnIGsfmS5ew2xofgpStNQx_Or3ImvsHlDhG-ZloYjNdGzabT5nRd6iXaM2CskgQv7LV-o6abpEqvW0_wq-L86uzy7BvvYBnJrJVKLiNpclS7VSknCp1VKIdbeNMW6N0qZRQePWNtkJYU5Uidi7NXGocWViRSfghHNRNbY-A2dTmUYl2i0XoJZIyN1IIZWORJxm-KQ7gZHMwxcJX2Cg6zzhXBXLQ98mUeQDf6NAKunerpa50nz6ARKiCVTFFZEPF8lMVwHhrJjK12ho-8sc-UEMqRIRoTLYEYZiRUOPDTIkAjjeSUfR3vS0SlEnUexEuH-8YFQgTFDknA_g6DNOeKLqtts26LeK8qwHE989IEGogNpQBfPLy-MgqRY7XGLd2uhHQR-I7-Ph5_98_hlc-GobKho7hYLVc2y_wtDXrCTybXt_czCbdzfsD17ojew
link.rule.ids 315,782,786,2733,27935,27936,48286,48348,48349,48360,49592,49653,49654,49665
linkProvider Nature Publishing
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_WlK2DsY_so16zVg8dezLzpyQ_hqYlY21e1kH7MiNbEvShdogTaP_73ll2SrYMNjD4QZLPPp3Ov-O-AI6VQIVXhIlf8hgNFBFzPxPG-ghlrS6CONEZ5Q5Pf4jZlZycUpkcv8-FaaPde5dkq6ldYrj8WlelC30U2Q7sUpnzZAC746vr68la9QoXZIiwIfARuURdQt5vyzd-QZ0iXtfRfDFXDXLHurYW23DnHz7T9ld09uo_P-I1vOwwJxs7IXkDT0w1hKeuC-X9EPZO-qZvQ3h20fna38IvlCBGwYestmy2sBG7qfAilNkYzfDWqkpW392jEDJK2USrm6lKs8lszLS6RVVFa-aUWIKQli1Xt9SHi7TrTfMOfp6dXp5M_a4bA24jT5c-j00odJooKwNpZaGCAk1rE6bKaKkKKblEbaCV4dzosuChtUlqE23J6Ap0FL-HQVVXZh-YSUwWFGjKGERjPCoyLTiXJuRZlOKTQg-O-w3K567oRt46y2OZIwdd60yRefCFNi-no7hcqFJ1GQVIhIpa5WMEO1Q_P5EejDZmIlPLjeF9t_1rakiFiBCNww2BWM-IqBdiKrkHB72E5N3xb_IIQSGqwgCXj7aMckQOkvyVHhyth-mdKOCtMvWqycOsLQsU_31GhOgD4aLw4IOTy0dWSfLFhvhqn3shfCS-hY8f_3HeEexNLy_O8_Nvs-8H8NxFzlCJ0REMlouV-QQ7jV4ddofyARJ-MQo
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swED_WlHWDsY9sa71mrR469mTqT0l-DE1Dy7Yw2AZjDzOyJUEfaofYgfa_311kJ2TLYDAw-EGSTz6dz7_jvgDOlECFV4SJX_IYDRQRcz8TxvoIZa0ugjjRGeUOX30Rs-9yckllcjatvijavXdJupwGqtJUtedzbbskcXleV6ULgxTZHuwnlIgwgP3p9Q8y1Ts1LFzAIUKIwEcUE3XJeb8t3_oddUp5XVPzyVw1yCnrWlzswqB_-E9Xv6Xps_94oefwtMOibOyE5wU8MNUQHrrulPdDeHTRN4MbwsGnzgf_En6iZDEKSmS1ZbOFjdhNhRehz8ZohreVCmX13T0KJ6NUTrTGmao0m8zGTKtbVGG0Zk4JJwh1Wbu8pf5cpHVvmlfwbXr59eLK77o04PHytPV5bEKh00RZGUgrCxUUaHKbMFVGS1VIySVqCa0M50aXBQ-tTVKbaEvGWKCj-DUMqroyR8BMYrKgQBPHIErjUZFpwbk0Ic-iFJ8UenDWH1Y-d8U48pUTPZY5ctC11BSZB-_pIHP6RNuFKlWXaYBEqNhVPkYQRHX1E-nBaGsmMrXcGj5yorCmhlSICNE42RKO9YyIeiSmkntw3EtL3qmFJo8QLKKKDHD5aMcoR0QhyY_pwel6mPZEgXCVqZdNHmarckHx32dEiEoQRgoPDp2MblglyUcb4tbe9QK5Ib6Dj2_-cd4pHHyeTPOP17MPx_DYBdRQ5dERDNrF0ryFvUYvT7rv8xdFSTnT
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+Nrf2+in+increased+reactive+oxygen+species+and+DNA+damage+in+prostate+tumorigenesis&rft.jtitle=Oncogene&rft.au=Frohlich%2C+D+A&rft.au=McCabe%2C+M+T&rft.au=Arnold%2C+R+S&rft.au=Day%2C+M+L&rft.date=2008-07-17&rft.pub=Nature+Publishing+Group+UK&rft.issn=0950-9232&rft.eissn=1476-5594&rft.volume=27&rft.issue=31&rft.spage=4353&rft.epage=4362&rft_id=info:doi/10.1038%2Fonc.2008.79&rft.externalDocID=10_1038_onc_2008_79
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon